In 2013, a clinical trial of ketamine in treatment-resistant depression used midazolam as an active placebo, finding 64% responders for ketamine and 28% for midazolam (Murrough et al., 2013), while the antidepressant effect was also confirmed to occur in bipolar depression (Diazgranados et al., 2010)
International patent timelines: Europe, Canada, and emerging markets Patent expiration dates vary by jurisdiction because filing dates, patent term adjustments, and supplementary protection certificates differ across countries
Explaining the long-term implications of their study, Dr
Consensus recommendations on sulfonylurea and sulfonylurea combinations in the management of type 2 diabetes mellitusInternational Task Force
Occupational Exposure
With all doses of FDA-approved Wegovy fully available nationwide, it is illegal under US compounding laws to make or sell knockoff "semaglutide" drugs, with rare exceptions New, one-time $199 first-month offer for Wegovy available through June 30, 2025